Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Evogen
AddedFeb 15, 2024
UpdatedJun 18, 2026
Evogen

Evogen

Pre-Seed

Evogen: Leading provider of air sampling solutions for military, government, and civilian use.

HQ
Kansas City, MO, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to offer cost-effective technologies that rapidly, accurately, and conveniently provide answers in neurology precision medicine, reagent technology, and biothreat analysis, Evogen is a leader in air sampling solutions. Their products and services are utilized across military, government, and civilian environments, focusing on protecting and saving lives while addressing unmet medical needs.

Evogen has made significant strides in the field of neurology proteomics and genomics, with their technologies being both lab-tested and real-world proven. The company has garnered attention from notable investors and industry leaders due to its innovative approach and impactful solutions. Evogen's contributions have significantly advanced threat detection and precision medicine, cementing its role as a critical player in these sectors.

Evogen - Similar Companies

Evon Medics logo

Evon Medics

Genendeavor logo

Genendeavor

genendeavor.com

Evolugate logo

Evolugate

evolugate.com

Genomind logo

Genomind

genomind.com

Evolv Technologies Holdings logo

Evolv Technologies Holdings

The Sampling Solutions logo

The Sampling Solutions

AirAnswers logo

AirAnswers

airanswers.com

EvoAktiv logo

EvoAktiv

evoagtec.com

Emtherapro logo

Emtherapro

emtherapro.com

Genetron Health logo

Genetron Health

genetronhealth.com

Novogenia logo

Novogenia

novogenia.com

EndGenitor Technologies logo

EndGenitor Technologies

Evozyne logo

Evozyne

evozyne.com

Neuron23 logo

Neuron23

Gencove logo

Gencove

gencove.com

Evogen - Quick Facts

Who are Evogen's competitors?

Companies similar to Evogen include Evon Medics, Genendeavor, Evolugate and Genomind.

When was Evogen founded?

Evogen was founded in 2011.

Where is Evogen's headquarters located?

Evogen's headquarters is located in Kansas City, MO, US.

When was Evogen's last funding round?

Evogen's most recent funding round was for $852.4k (USD) in February 2014.

How much has Evogen raised to-date?

As of Feb 19, 2014, Evogen has raised a total of $6.4M (USD).

How many employees does Evogen have?

Evogen has 5 employees as of Feb 4, 2024.

Evogen - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Air Sampling
  • Biotechnology
Tags
  • Biotech
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified